| Aug 1 |
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
|
| Aug 1 |
AVITA signs dermal matrix distribution agreement with Regenity
|
| Jul 31 |
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
|
| Jul 11 |
AVITA Medical to Announce Second Quarter 2024 Financial Results
|
| Jul 1 |
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
|
| Jun 26 |
Institutions own 46% of AVITA Medical, Inc. (NASDAQ:RCEL) shares but retail investors control 50% of the company
|
| Jun 5 |
AVITA Medical Achieves Milestone with First Case Using RECELL GO
|
| May 31 |
Avita obtains FDA approval for cell harvesting device Recell GO System
|
| May 30 |
AVITA spikes on FDA nod for RECELL GO cell harvesting device
|
| May 30 |
AVITA Medical Announces FDA Approval of RECELL GO
|
